Relationship Between ORI and Blood Transfusion in Spinal Surgery
Investigation of the Relationship Between Perioperative Blood Transfusion and Intraoperatively Monitored Oxygen Reserve Index (ORI) in Patients Scheduled for Vertebral Stabilization Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
Concerns about the necessity and risks of blood transfusions have led to the search for new noninvasive monitoring methods. Oxygen reserve index (ORI), one of them, is a dimensionless index ranging from 0.00 (no reserve) to 1.00 (maximum reserve) according to oxygenation reserve status, and it is also a non-invasive and continuous measurement parameter. Some studies have examined ORi as an indicator for early detection of hypoxemia. There are reports in the literature that ORi and Pa02 values measured noninvasively during surgery are early precursors for desaturation and hypoxia.Researces aimed to investigate the relationship between perioperative blood transfusions and ORI in vertebral stabilization surgeries performed by the same surgical team in our clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2022
CompletedFirst Submitted
Initial submission to the registry
May 8, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedMay 22, 2023
May 1, 2023
6 months
May 8, 2023
May 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative ORI values
Monitoring ORI values at the beginning of surgery and values measured every 15 minutes during surgery
Perioperative process (2-5 hours)
Secondary Outcomes (1)
Perioperative blood transfusion prediction
Perioperative process (2-5 hours)
Interventions
hourly blood gas analysis and hemoglobin and hematocrit control and blood transfusion will be performed when necessary If a low pO2 value is observed in the blood gas, the fi02 values or fresh gas flow will be increased.
Eligibility Criteria
Elective patients planned stabilization surgery
You may qualify if:
- Patients over 18 years of age in ASA I-III risk class
- Patients who will undergo vertebral stabilization surgery at 3 levels or more under general anesthesia (lumbar disc herniation, lumbar spinal stenosis, lumbar spondylolisthesis and other lumbar spine pathologies)
- who are expected to lose \>500 ml of blood
- Patients who require arterial catheter placement for continuous monitoring of blood pressure and/or analysis of arterial blood gas during surgery
You may not qualify if:
- Patients with coagulation disorders, thrombocytopenia, liver and kidney disease
- Patients receiving regular anticoagulant and antiplatelet therapy
- Patients who will undergo revision surgery
- Patients who will undergo surgery due to spinal tumor or infection
- Patients with perioperative tranexamic acid and/or antifibrinolytic use
- Patients with preoperative hemoglobin values \<12 g/dl in women and \<13 g/dl in men or patients with preoperative anemia due to hemoglobinopathies (e.g. thalassemia, sickle cell disease anemia)
- Patients with congestive heart failure
- Inability to attach the sensor due to deformity of the fingers
- Inability to attach the sensor due to hypoperfusion of the fingers: thalassemia, sickle cell disease anemia)
- Patients with congestive heart failure
- Inability to wear the sensor due to deformity of the fingers
- Patients who would show an inadequate signal due to hypoperfusion of the fingers were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa Training and Research Hospital
Bursa, 16600, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Asiye A Demirel, MD
Bursa Yuksek Ihtisas Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 8, 2023
First Posted
May 22, 2023
Study Start
December 15, 2022
Primary Completion
June 15, 2023
Study Completion
June 15, 2023
Last Updated
May 22, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share